Clinical Trials in Boston

Showing 2881-2900 of 17,836 trials

Walking After Traumatic Brain Injury in Older Adults

NCT06222502

The purpose of this research is to learn if different behavioral interventions can change walking behaviors over 12-weeks, in older adults who have previously suffered a non-penetrating mild or moderate TBI. Participants will provide information and be screened for eligibility via phone screening call (verification of age, confirmation that the participant is not currently on any medication that affects the central nervous system, and verification that the subject can participate in exercise, brief TBI history). Baseline testing will take place at the Center for Cognitive and Brain Health and Northeastern University Biomedical Imaging Center, for the baseline magnetic resonance imaging, in the interdisciplinary science and engineering complex on Northeastern University's campus. In person testing will take place over one session. The study period lasts 12 weeks, during which all participants will 1. Receive a weekly phone call with study staff and 2. Wear a wrist-worn Fit Bit tracker. A remote participation option is available for those who cannot travel to Northeastern University.

Traumatic Brain InjuryTBIMild Traumatic Brain Injury+1 more

Timothy Morris57 participantsStarted Apr 2024

Boston, Massachusetts, United States

RECRUITINGPhase 1< 1 mile

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

This is a first-in-human, open-label, multicenter, Phase 1 study to evaluate the safety, tolerability and preliminary efficacy of IPH4502 and to determine the recommended Phase 2 dose (RP2D) in advanced solid tumors that are known to express Nectin-4

Advanced or Metastatic Solid Tumors

Innate Pharma145 participantsStarted Jan 2025

Boston, Massachusetts, United States • Hackensack, New Jersey, United States • New York, New York, United States +4 more locations

Walking After Traumatic Brain Injury in Older Adults

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Find Trials by Condition in Boston

Allied Cleft & Craniofacial Quality-Improvement and Research Network (ACCQUIREnet)

Treating Young Children With Attention Deficit Hyperactivity Disorder

Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency

AB154 Combined With AB122 for Recurrent Glioblastoma

Fetal Treatment of Galenic Malformations

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma

[18F]PI-2620 Phase 3 Histopathological Study

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH)

Low INR to Minimize Bleeding With Mechanical Valves Trial

Biodesign® Otologic Repair Graft

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.